Discovery of a novel USP10 inhibitor with improved aqueous solubility for the treatment of hepatocellular carcinoma
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2025.109348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Wentao Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Ubiquitin Thiolesterase, Antineoplastic Agents. Die Arbeit nennt 56 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Ubiquitin-specific protease 10 (USP10) has emerged as an attractive target for cancer therapy. Building upon our previously identified lead compound, LY-2, this study reports the discovery of WW-104, a USP10 inhibitor exhibiting enhanced solubility and potent enzymatic activity. Surface plasmon resonance and enzymatic assays delineated its binding mode and demonstrated appreciable selectivity for USP10 over USP7. WW-104 significantly suppressed the proliferation and colony formation of hepatocellular carcinoma cells and induced G2-phase arrest accompanied by apoptosis. Moreover, this work provides a practical solubility determination protocol that may facilitate future optimization of the drug-like properties of deubiquitinase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China; Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangz…
- State key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023,…
- State key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: chejx@zju.edu.cn.
- College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China. Electronic address: dongxw@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, W., Luo, M., Wang, C., Lu, Y., Wang, P., Hu, L., Li, B., Yuan, C., Zhou, Y., Che, J., & Dong, X. (2026). Discovery of a novel USP10 inhibitor with improved aqueous solubility for the treatment of hepatocellular carcinoma. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2025.109348
Vancouver
Wang W, Luo M, Wang C, Lu Y, Wang P, Hu L, et al. Discovery of a novel USP10 inhibitor with improved aqueous solubility for the treatment of hepatocellular carcinoma. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2025.109348
BibTeX
@article{Wang2026,
author = {Wang, Wentao and Luo, Mengxin and Wang, Chenxi and Lu, Yang and Wang, Peipei and Hu, Liuzhi and Li, Bizhi and Yuan, Cheng and Zhou, Yubo and Che, Jinxin and Dong, Xiaowu},
title = {Discovery of a novel USP10 inhibitor with improved aqueous solubility for the treatment of hepatocellular carcinoma},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2025.109348}
}
EUVIMED